Your browser doesn't support javascript.
loading
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential.
Zhang, Chunye; Stelloo, Ellen; Barrans, Sharon; Cucco, Francesco; Jiang, Dan; Tzioni, Maria-Myrsini; Chen, Zi; Li, Yan; Swennenhuis, Joost F; Makker, Jasmine; Rásó-Barnett, Lívia; Liu, Hongxiang; El-Daly, Hesham; Soilleux, Elizabeth; Shah, Nimish; Nagumantry, Sateesh Kumar; Kyaw, Maw; Prahladan, Mahesh Panatt; Tooze, Reuben; Westhead, David R; Feitsma, Harma; Davies, Andrew J; Burton, Catherine; Johnson, Peter W M; Du, Ming-Qing.
Afiliação
  • Zhang C; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Stelloo E; Department of Oral Pathology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
  • Barrans S; Cergentis BV, Utrecht, Netherlands.
  • Cucco F; Haematological Malignancy Diagnostic Service, St James' University Hospital, Leeds, UK.
  • Jiang D; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Tzioni MM; Institute of Clinical Physiology, CNR, Pisa, Italy.
  • Chen Z; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Li Y; East Genomic Laboratory Hub, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Swennenhuis JF; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Makker J; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Rásó-Barnett L; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Liu H; Department of Haematology, Hebei General Hospital, Shijiazhuang, PR China.
  • El-Daly H; Cergentis BV, Utrecht, Netherlands.
  • Soilleux E; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Shah N; The Haematopathology and Oncology Diagnostic Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Nagumantry SK; East Genomic Laboratory Hub, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Kyaw M; Cellular Pathology Department, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
  • Prahladan MP; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Tooze R; Department of Haematology, Norfolk and Norwich University Foundation Hospital, Norwich, UK.
  • Westhead DR; Department of Haematology, Peterborough City Hospital, Peterborough, UK.
  • Feitsma H; Department of Haematology, James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK.
  • Davies AJ; East Suffolk and North Essex Foundation Trust, Suffolk, UK.
  • Burton C; Haematological Malignancy Diagnostic Service, St James' University Hospital, Leeds, UK.
  • Johnson PWM; Division of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
  • Du MQ; School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK.
Leukemia ; 38(3): 621-629, 2024 03.
Article em En | MEDLINE | ID: mdl-38184753
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article